Detailed answers about INTERMED GLOBAL FZE LTD, including incorporation, status, business activity, and accounts information.
When was INTERMED GLOBAL FZE LTD founded?
INTERMED GLOBAL FZE LTD was officially incorporated on 20 June 2026 and is registered under company number 17290116. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INTERMED GLOBAL FZE LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of INTERMED GLOBAL FZE LTD?
INTERMED GLOBAL FZE LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INTERMED GLOBAL FZE LTD do?
INTERMED GLOBAL FZE LTD operates in the following sectors: 46900 - Non-specialised wholesale trade, 47190 - Other retail sale in non-specialised stores, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 47789 - Other retail sale of new goods in specialised stores (not commercial art galleries and opticians). These SIC codes provide insight into the company's business activities and industry focus.
What is INTERMED GLOBAL FZE LTD's registered address?
The registered office address of INTERMED GLOBAL FZE LTD is Unit 7 Initial Business Centre, Wilson Business Park, Manchester, United Kingdom, M40 8WN. This is the official address filed with Companies House for legal and statutory correspondence.
Is INTERMED GLOBAL FZE LTD financially stable?
Financial accounts for INTERMED GLOBAL FZE LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.